• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-

tetano

Editor, Senior Moderator
J Infect Chemother


. 2022 Dec 22;S1341-321X(22)00330-0.
doi: 10.1016/j.jiac.2022.12.007. Online ahead of print.
Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19


Naoyuki Miyashita[SUP] 1 [/SUP], Yasushi Nakamori[SUP] 2 [/SUP], Makoto Ogata[SUP] 3 [/SUP], Naoki Fukuda[SUP] 3 [/SUP], Akihisa Yamura[SUP] 3 [/SUP], Yoshihisa Ishiura[SUP] 4 [/SUP]



Affiliations

Abstract

Introduction: The Japanese Respiratory Society (JRS) pneumonia guidelines recommend simple predictive rules, the A-DROP scoring system, for assessment of the severity of community-acquired pneumonia (CAP) and nursing and healthcare-associated pneumonia (NHCAP). We evaluated whether the A-DROP system can be adapted for assessment of the severity of coronavirus disease 2019 (COVID-19) pneumonia.
Methods: Data from 1141 patients with COVID-19 pneumonia were analyzed, comprising 502 patients observed in the 1st to 3rd wave period, 338 patients in the 4th wave and 301 patients in the 5th wave in Japan.
Results: The mortality rate and mechanical ventilation rate were 0% and 1.4% in patients classified with mild disease (A-DROP score, 0 point), 3.2% and 46.7% in those with moderate disease (1 or 2 points), 20.8% and 78.3% with severe disease (3 points), and 55.0% and 100% with extremely severe disease (4 or 5 points), indicating an increase in the mortality and mechanical ventilation rates in accordance with severity (Cochran-Armitage trend test; p = <0.001). This significant relationship between the severity in the A-DROP scoring system and either the mortality rate or mechanical ventilation rate was observed in patients with COVID-19 CAP and NHCAP. In each of the five COVID-19 waves, the same significant relationship was observed.
Conclusions: The mortality rate and mechanical ventilation rate in patients with COVID-19 pneumonia increased depending on severity classified according to the A-DROP scoring system. Our results suggest that the A-DROP scoring system can be adapted for the assessment of severity of COVID-19 CAP and NHCAP.

Keywords: A-DROP; COVID-19; Community-acquired pneumonia; Nursing and healthcare-associated pneumonia; Pneumonia severity; SARS-CoV-2.
 
Back
Top Bottom